Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/3338
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorINCA-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorSistema Único de Saúde (Brasil)-
dc.contributor.authorBrasil. Ministério da Saúde-
dc.date.accessioned2021-07-13T17:06:39Z-
dc.date.available2021-07-13T17:06:39Z-
dc.date.issued2019-08-
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/3338-
dc.description1 p.-
dc.language.isootherpt_BR
dc.publisherINCApt_BR
dc.relation.ispartofseriesAno III, n. 29.-
dc.subjectTrastuzumabpt_BR
dc.subjectQuimioterapiapt_BR
dc.subjectTratamento Farmacológicopt_BR
dc.subjectDrug Therapypt_BR
dc.subjectNeoplasias da Mama-
dc.subjectBreast Neoplasms-
dc.subjectNeoplasias de la Mama-
dc.titleTrastuzumabe para quimioterapia paliativa de pacientes que fizeram uso prévio de trastuzumabept_BR
dc.TypeRevistas/Boletinspt_BR
Appears in Collections:Informe SUS - ONCO 2019

Files in This Item:
File Description SizeFormat 
informe-sus-onco-agosto-2019.pdf450.48 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.